Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants

The production of therapeutic antibodies to combat pathogens and treat diseases, such as cancer is of great interest for the biotechnology industry. The recent development of plant-based expression systems has demonstrated that plants are well-suited for the production of recombinant monoclonal anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dicker, Martina, Tschofen, Marc, Maresch, Daniel, König, Julia, Juarez, Paloma, Orzaez, Diego, Altmann, Friedrich, Steinkellner, Herta, Strasser, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Plant Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731523/
https://www.ncbi.nlm.nih.gov/pubmed/26858738
http://dx.doi.org/10.3389/fpls.2016.00018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731523/
https://www.ncbi.nlm.nih.gov/pubmed/26858738
http://dx.doi.org/10.3389/fpls.2016.00018

Ejemplares similares